N-Power Medicine Emerges with Series B Funding to Bolster Access to Innovative Oncology Clinical Trials
• Series B led by Merck Global Health Innovation Fund• First-of-its-kind integrated data platform provides infrastructure support for both clinical trials and routine patient management• 7,000 patients enrolled in Kaleido Registry July 01, 2024 05:00 AM Pacific Daylight…